Literature DB >> 657182

Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.

G Neugebauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 657182     DOI： 10.1093/cvr/12.4.247

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  29 in total

1.  Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers.

Authors:  D N John; S Fort; M J Lewis; D K Luscombe
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

2.  Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.

Authors:  Forough Sanaee; John D Clements; Alistair W G Waugh; Richard N Fedorak; Richard Lewanczuk; Fakhreddin Jamali
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

3.  The effect of verapamil on cardiovascular and metabolic responses to exercise.

Authors:  H Petri; B G Arends; M A van Baak
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

Review 4.  Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

5.  Once a day verapamil in essential hypertension.

Authors:  F B Müller; H R Ha; H Hotz; O Schmidlin; F Follath; F R Bühler
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

6.  Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man.

Authors:  R Padrini; E Barbieri; D Piovan; M Toffoli; A Motta; G P Trevi; M Ferrari
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Effect of levosimendan in experimental verapamil-induced myocardial depression.

Authors:  Jouni Kurola; Heli Leppikangas; Jarkko Magga; Leena Lindgren; Vesa Kiviniemi; Juha Rutanen; Esko Ruokonen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-03-11       Impact factor: 2.953

8.  R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate.

Authors:  J H Ahmed; J Godden; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

Review 9.  Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine.

Authors:  P D Pearigen; N L Benowitz
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 10.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.